Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market
Holding EGRX?
Track your performance easily

Eagle Pharmaceuticals (EGRX) Balance Sheet

208 Followers

Eagle Pharmaceuticals Balance Sheet

Eagle Pharmaceuticals's total assets for Q2 2023 were $404.82M, a decrease of -2.26% from the previous quarter. EGRX total liabilities were $152.78M for the fiscal quarter, a -10.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 406.16M$ 253.73M$ 253.19M$ 254.55M$ 238.60M
Total Liabilities
$ 172.60M$ 77.28M$ 67.18M$ 75.38M$ 77.84M
Total Equity Gross Minority
$ 233.56M$ 176.45M$ 186.01M$ 179.17M$ 160.76M
Total Capitalization
$ 345.99M$ 202.45M$ 236.28M$ 212.73M$ 198.92M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Eagle Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis